Keith Dunleavy's Companies: From Inovalon to SpaceX

Quick answer

Keith Dunleavy's companies are Inovalon and Apandion — one he built, one he funds. Inovalon, the healthcare data-analytics company he founded in 1998 and ran as CEO for 26 years, is the empire: taken public in 2015, sold for $7.3 billion in 2021, and still ~15% owned by Dunleavy, who sits on its board. Apandion, his self-funded investment firm, is the second act: Forbes names SpaceX — backed before its June 2026 IPO — and Shield AI among its investments. Together they underpin his $4.6 billion fortune and his September 2026 Forbes 400 debut at rank #375. For the numbers, see Keith Dunleavy's net worth.

Inovalon: the empire he built

Inovalon is the company that made Keith Dunleavy. Conceived during his Johns Hopkins internal medicine residency, founded in 1998, taken public on the Nasdaq (INOV) in 2015, and taken private again in 2021, it is one of the largest healthcare data platforms in the United States. The Inovalon ONE Platform connects national-scale healthcare data with real-time analytics, and by September 2026 it was informed by the primary-source data of more than 99 billion medical, pharmacy, and lab events across 461 million unique lives, serving over 50,000 active, licensed customers.

Dunleavy's relationship with the company today is owner-director, not operator. He retired as CEO on March 1, 2025, handing the role to Adam Kansler after overseeing the IPO, the take-private, a three-year transformation into a pure-play cloud SaaS and data platform provider, and the integration of AI across the product portfolio. He remains a significant shareholder — Forbes says roughly 15% — and a board member. The Bowie, Maryland headquarters has never moved.

The 2021 consortium deal

The ownership map of Inovalon changed on August 19, 2021, when the company agreed to be acquired by an equity consortium led by Nordic Capital, joined by Insight Partners as lead co-investor, 22C Capital, and Dunleavy himself alongside certain Class B stockholders. The all-cash transaction carried an enterprise value of approximately $7.3 billion, with shareholders receiving $41.00 per share — a 25.3% premium over the last unaffected closing price.

The deal's structure is the key to Dunleavy's current holdings. Merger disclosures said he owned and controlled about 64% of Inovalon's stock going in. Rather than taking all cash, he rolled a large portion into the private company as a co-investor — a vote of confidence that kept him as a substantial shareholder and, later, a board member after his 2025 CEO retirement. Nordic and Insight brought software and healthcare expertise; Dunleavy brought the founder's continuity.

Apandion: the self-funded second act

After the 2021 sale, Dunleavy founded Apandion — and its structure is the tell. The firm is backed solely by his own funds: no outside limited partners, no fundraising, no fee pressure. Its mandate, per Forbes, is an emphasis on founder-led technology firms — companies run by the people who started them, the way Inovalon was run by him.

This is the classic post-exit founder vehicle, with a purist twist. Most billionaires park money in a diversified family office; Dunleavy built a concentrated bet machine on founders. The two disclosed names — SpaceX and Shield AI — are both founder-led, capital-intensive technology companies. Whatever else Apandion holds is not public, but the philosophy is: back operators who remind him of himself.

SpaceX: the rocket bet

The most consequential Apandion position is SpaceX. Forbes says Apandion became a pre-IPO backer of the rocket company, and Dunleavy's Forbes profile lists Space Exploration Technologies Corp. (SPCX-US) among his financial assets. Coverage of the 2026 Forbes 400 newcomers explicitly credited the stake with his debut: he "made the cut after his self-funded investment firm, Apandion, became a pre-IPO backer of SpaceX."

The timing was the trade. SpaceX's June 2026 IPO — described as a blockbuster — converted years of private-company appreciation into liquid, listed value. For Dunleavy, the SpaceX position did in one listing what took Inovalon decades: a step-change in net worth. It is also a neat symmetry — the healthcare data founder riding the defining technology IPO of the year through a firm he funded himself.

Shield AI: the defense-tech bet

The other named Apandion investment is Shield AI, the San Diego company founded in 2015 by brothers Brandon and Ryan Tseng with Andrew Reiter, building AI pilots — "Hivemind" — that let aircraft operate autonomously without GPS or human remote control. Its V-BAT drones are deployed with the U.S. Navy and in Ukraine, and the company has raised at multi-billion-dollar valuations through 2026.

Shield AI fits the Apandion thesis perfectly: founder-led, deep technology, mission-driven. It also rhymes with Dunleavy's philanthropy — the Dunleavy Foundation he created with his wife in 2020 supports U.S. service members and veterans, among other causes. A defense-tech investment and a veterans-focused foundation are two sides of the same conviction.

The foundation: giving it back

Not every Dunleavy entity is a for-profit company. In 2020, he and his wife created the Dunleavy Foundation, which supports education, social entrepreneurship, and U.S. service members and veterans. It is the one institution in his portfolio that spends money rather than making it — and it connects to the rest: the veterans' cause rhymes with the Shield AI defense-tech bet, and the education focus echoes his own path from Dartmouth to Harvard to Johns Hopkins.

The foundation also fits the low-profile pattern. There are no splashy naming gifts or headline donation announcements attached to it in the public record — just the Forbes-profile line describing its mission. For a man who kept his CEO salary at $205,000 and his face out of the press, quiet philanthropy is on brand.

What he no longer runs — and what comes next

Dunleavy stepped down as Inovalon CEO on March 1, 2025, after 26 years. He is an owner and board member now, not an operator — which makes Apandion his primary professional identity going forward. The open question is what Apandion backs next: the firm's disclosed portfolio is just SpaceX and Shield AI, but a self-funded vehicle with a $4.6 billion backer has room for more founder-led bets.

The through-line across all his companies is concentration. One company for 26 years. One investment firm, funded by himself. A handful of founder-led bets. It is the same philosophy that kept his CEO salary at $205,000 — he never needed diversification of income because he had concentration of ownership. For that story, see Keith Dunleavy's salary — and for how his company-building compares to a peer, Dunleavy vs. August Troendle.

Frequently asked questions